SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Agent 10/27/14 Paratek Pharmaceuticals, Inc. S-4MEF 10/27/14 12:143K Donnelley … Solutions/FA |
Document/Exhibit Description Pages Size 1: S-4MEF Registration of Additional Securities HTML 44K 2: EX-5.1 Opinion re: Legality HTML 18K 3: EX-8.1 Opinion re: Tax Matters HTML 22K 4: EX-8.2 Opinion re: Tax Matters HTML 18K 5: EX-23.1 Consent of Experts or Counsel HTML 7K 6: EX-23.2 Consent of Experts or Counsel HTML 8K 7: EX-99.1 Miscellaneous Exhibit HTML 7K 8: EX-99.2 Miscellaneous Exhibit HTML 8K 9: EX-99.3 Miscellaneous Exhibit HTML 8K 10: EX-99.4 Miscellaneous Exhibit HTML 8K 11: EX-99.5 Miscellaneous Exhibit HTML 8K 12: EX-99.6 Miscellaneous Exhibit HTML 8K
EX-23.2 |
Exhibit 23.2
Consent of Independent Registered
Public Accounting Firm
We consent to the incorporation by reference in this Registration Statement on Form S-4 of Transcept Pharmaceuticals, Inc. of our report, which includes an explanatory paragraph related to Paratek Pharmaceuticals, Inc.’s ability to continue as a going concern, dated August 28, 2014, on our audits of the financial statements of Paratek Pharmaceuticals, Inc. as of December 31, 2013 and 2012 and for the years then ended, which report is included in Amendment No. 1 to the Registration Statement on Form S-4 (333-198464) of Transcept Pharmaceuticals, Inc. We also consent to the reference to our firm under the caption “Experts” in Amendment No. 1 to the Registration Statement on Form S-4 incorporated by reference in this Registration Statement.
/s/ CohnReznick LLP
Vienna, Virginia
This ‘S-4MEF’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on / Effective on: | 10/27/14 | |||
8/28/14 | ||||
12/31/13 | 10-K | |||
12/31/12 | 10-K | |||
List all Filings |